EICHOR
● Recruiting
Evaluate the Efficacy of Using Modified Qing-Ying Decoction in Atopic Dermatitis Children
Condition: Atopic Dermatitis · Sponsor: Chinese University of Hong Kong
About this study
The study aims to evaluate the clinical efficacy and safety of the modified Qing-Ying Decoction (mQYD) for the treatment of subacute and chronic atopic dermatitis (AD) in children when compared to the placebo control through examining the clinical symptoms, quality of life, gut microbiome, and Chinese medicine body constitution. This is a parallel, randomized, placebo-controlled, double-blind clinical trial. Eligible subjects will be randomly allocated to receive oral mQYD granules or it's placebo granules. Subjects will have 12-week of treatment, and then a 4-week follow-up.
This description comes directly from the study's public registry record.
Talk to the study team
Chi-him Sum · 39433438 · chsum@cuhk.edu.hk
Always discuss trial participation with your own doctor first.
Locations (1)
| The Chinese University of Hong Kong | Hong Kong, Hong Kong | Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04419584